|
|
Effect of dexmedetomidine on hepatic function in patients undergone laparoscopic cholecytectomy with CO2 pneumoperitoneum |
1.Department of Anesthesiology, the Second Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325027; 2.Department of Anesthesiology, the Third Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325200
|
|
Cite this article: |
CHEN Li1,2,LU Bin2, et al. Effect of dexmedetomidine on hepatic function in patients undergone laparoscopic cholecytectomy with CO2 pneumoperitoneum[J]. JOURNAL OF WEZHOU MEDICAL UNIVERSITY, 2015, 45(9): 687-.
|
|
Abstract Objective: To evaluate the effect of dexmedetomidine on hepatic function in patients undergone laparoscopic cholecystectomy with CO2 pneumoperitoneum. Methods: Sixty patients aged 18–60 years, whose pneumoperitoneum duration varied from 0.5 to 1 h and matched ASA I-II, were randomly divided into two groups: control group (group C, n=30) and dexmedetomidine group (group D, n=30). In group D, dexmedetomidine was infused intravenously at a rate of 1 μg•kg-1 for 10 min, followed by 0.3 μg•kg-1•h-1 until the end of the operation, while in group C equal volume of 0.9% sodium chloride solution was infused after trachea intubation. Peripheral vein blood samples were collected immediately before anesthesia (T0, baseline), 1 h (T1) and 24 h (T2) after pneumoperitoneum released for measurement of serum alanine aminotransferase (ALT), aspartate aminotransferase (AST), plasma IL-6, TNF-α, malondialdehyde (MDA) and superoxide dismutase (SOD) levels. Results: Compared with T0 point, the serum ALT, AST activities were significantly increased at T2 in both groups. Compared
with group C, the serum ALT, AST, plasma TNF-α and IL-6 were significantly descreased at T2 and the serum MDA was significantly descreased at T1, T2 and the levels of plasma SOD at T1 was significantly increased in group D (P<0.05). Conclusion: Hepatic injury in patients undergone laparoscopic cholecystectomy with CO2 pneumoperitoneum can be attenuated by dexmedetomidine via inhibiting inflammatory responses and lipid peroxidation.
|
Received: 06 March 2015
|
|
|
|
|
[1] Gupta R, Kaman L, Dahiya D, et al. Effects of varying intraperitoneal pressure on liver function tests during laparoscopic cholecystectomy[J]. J Laparoendosc Adv Surg Tech A, 2013, 23(4): 339-342.
[2] Lai H, Mo X, Yang Y, et al. Association between duration of carbon dioxide pneumoperitoneum during laparoscopic abdominal surgery and hepatic injury: a meta-analysis[J].PLoS One, 2014, 9(8): e104067.
[3] Yoshitomi O, Cho S, Hara T, et al. Direct protective effects of dexmedetomidine against myocardial ischemia-reperfusion injury in anesthetized pigs[J]. Shock, 2012, 38(1): 92-97.
[4] Wang ZX, Huang CY, Hua YP, et al. Dexmedetomidine reduces intestinal and hepatic injury after hepatectomy with inflow occlusion under general anaesthesia: a randomized controlled trial[J]. Br J Anaesth, 2014, 112(6): 1055-1064.
[5] Sakorafas G, Anagnostopoulos G, Stafyla V, et al. Elevation of serum liver enzymes after laparoscopic cholecystectomy [J]. N Z Med J, 2005, 118(1210): U1317.
[6] 高成顺, 王立明, 熊君宇, 等. 异丙酚对家兔CO2气腹时肝损伤的影响[J]. 中华麻醉学杂志, 2010, 30(11): 1400-1401.
[7] 周正东, 陈训如, 罗丁, 等. 腹腔镜胆囊切除术中高频电刀对肝脏损伤的影响[J]. 肝胆外科杂志, 2003, 11(3): 195-197.
[8] Ozmen MM, Zulfikaroglu B, Col C, et al. Effect of increased abdominal pressure on cytokines (IL1b, IL6, TN-Falpha), C-reactive protein (CRP), free radicals (NO, MDA), and histology[J]. Surg Laparosc Endosc Percutan Tech, 2009, 19(2): 142-147.
[9] 陆斌, 张序忠, 胡世特, 等. 右美托咪定对肢体缺血再灌注致患者肺损伤的影响[J]. 中华麻醉学杂志,2014, 34(9): 1045-1047.
[10] Freiats MC, Uchida Y, Zhao D, et al. Blockade of Janus kinase-2 signaling ameliorates mouse liver damage due to ischemia and reperfusion[J]. Liver Transpl, 2010, 16(5): 600-610. |
|
|
|